Skip to main content
logo
Verona Pharma plc (VRNA)
Oct 7, 2025 - VRNA was delisted (reason: acquired by MRK)
106.91
+0.12 (0.11%)
Inactive · Last trade price on Oct 6, 2025

Verona Pharma Ratios and Metrics

Millions USD. Fiscal year is Jan - Dec.

Total Valuation

Fiscal Year
CurrentFY 2024FY 2023FY 2022FY 2021FY 2020
Period Ending
Oct '25 Dec '24 Dec '23 Dec '22 Dec '21 Dec '20
Market Capitalization
9,2153,8001,7092,133444405
Market Cap Growth
278.24%122.40%-19.89%380.79%9.47%435.09%
Enterprise Value
9,0213,5871,4721,907283205
Last Close Price
106.9146.4419.8826.136.727.00

Price Ratios

Fiscal Year
CurrentFY 2024FY 2023FY 2022FY 2021FY 2020
Period Ending
Oct '25 Dec '24 Dec '23 Dec '22 Dec '21 Dec '20
PS Ratio
40.3989.89-4657.4011.09-
PB Ratio
33.0418.586.859.263.002.19
P/TBV Ratio
33.1818.636.879.283.012.20

EV Ratios

Fiscal Year
CurrentFY 2024FY 2023FY 2022FY 2021FY 2020
Period Ending
Oct '25 Dec '24 Dec '23 Dec '22 Dec '21 Dec '20
EV/Sales Ratio
40.7084.83-4164.237.09-

Financial Efficiency

Fiscal Year
CurrentFY 2024FY 2023FY 2022FY 2021FY 2020
Period Ending
Oct '25 Dec '24 Dec '23 Dec '22 Dec '21 Dec '20
Debt / Equity Ratio
0.881.120.210.050.040.03
Asset Turnover
0.440.11-0.000.21-
Quick Ratio
10.2510.2432.5312.464.9113.82
Current Ratio
10.7110.6333.3312.775.0914.26
Return on Equity (ROE)
-36.36%-76.42%-22.67%-36.30%-33.39%-57.25%
Return on Assets (ROA)
-6.68%-24.13%-14.64%-18.53%-18.45%-31.68%
Return on Invested Capital (ROIC)
-8.28%-25.72%-15.34%-20.93%-20.92%-35.14%

Yields

Fiscal Year
CurrentFY 2024FY 2023FY 2022FY 2021FY 2020
Period Ending
Oct '25 Dec '24 Dec '23 Dec '22 Dec '21 Dec '20
Earnings Yield
-0.88%-4.56%-3.18%-3.22%-12.53%-16.07%
FCF Yield
-0.80%-3.23%-2.94%-2.81%-7.50%-11.14%
Buyback Yield / Dilution
-4.09%-2.86%-19.86%-11.81%-79.97%-149.64%
SEC Filings: 10-K · 10-Q